Menu
Menu
The need for more effective treatments of mental health issues is a nationally recognized challenge in psychiatry and psychology. Research findings strongly support the efficacy of psychedelic medicines for several clinical symptomologies and clinical trials are underway in the US, UK and EU that will likely result in the availability of MDMA and psilocybin for legal use in US medical clinics for PTSD and depression, respectively, within 2 to 4 years. Within the next several years there is a national need to train medical and mental health professionals who wish to be ready to conduct psychedelic-assisted psychotherapy.
This recording will begin with a review of the clinical research outcomes on psychedelic-assisted therapy for depression, anxiety, PTSD, end-of-life distress, and substance abuse. We will discuss the professional training being done by the Multidisciplinary Association of Psychedelic Studies (MAPS) and the California Institute of Integral Studies (CIIS). The recording will offer some of the teachings from the CIIS professional training program, which includes neuropharmacology and research foundations, global transformational traditions, mindfulness practices, therapist competencies, and en vivo instruction. An engaging discussion will follow the presentation on questions about the place for such training for licensed psychotherapists and medical professionals, the future of the research, and where psychedelics fit within the newest innovations in the mental health field.
| File type | File name | Number of pages | |
|---|---|---|---|
| Manual - Psychedelic-Assisted Therapy (1.9 MB) | 35 Pages | Available after Purchase | |
| Transcript (79.5 KB) | 20 Pages | Available after Purchase | |
| Manual - Psychedelic-Assisted Therapy - French (1.9 MB) | 35 Pages | Available after Purchase | |
| Transcript - French (79.5 KB) | 20 Pages | Available after Purchase | |
| Manual - Psychedelic-Assisted Therapy - Italian (1.9 MB) | 35 Pages | Available after Purchase | |
| Transcript - Italian (79.5 KB) | 20 Pages | Available after Purchase |
Janis Phelps, PhD, leads The Center for Psychedelic Therapy & Research. Dr. Phelps received her doctorate in clinical psychology from the University of Connecticut. She has been a professor at the California Institute of Integral Studies (CIIS) for the past 21 years. She is the former dean of the School of Consciousness and Transformation at CIIS. She is now the Director of the CIIS Center for Psychedelic Therapies and Research. As the Center's founder, she developed the first academically accredited, professional certificate training program for legal psychedelic-assisted therapy and research. The Center also provides harm reduction workshops, webinars on psychedelic research and public educational programs. A licensed clinical psychologist and LMFT, she has held faculty positions in the East-West therapy models; Buddhism and Eastern disciplines; and phenomenology/existential philosophies. Her research and scholarly writing have focused on psychedelic therapy, entheogens, and mind-body wellness. Dr. Phelps teaches graduate courses in quantitative and qualitative research methods, mindfulness, Buddhism and psychotherapy, spiritual counseling, and principles of healing. Janis serves on the board of the Holos Institute and maintains a private practice.
Speaker Disclosures:
Financial: Dr. Janis Phelps is the director and founder of the Center for Psychedelic Therapies and Research. She is a consulting psychologist and receives compensation. Dr. Phelps receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Janis Phelps is a founding advisory board member of the Holos Institute and a board member of the Institute for Spirituality and Psychology. She is a member of the Association for Transpersonal Psychology and the California Psychological Association
Please wait ...